Awarded contract

Herpes zoster, inactivated vaccine (2027)

Details

Duration
3 years
Topic
Vaccines
Published
13 March 2026

Tender description

The provision of a vaccine to protect against herpes zoster, also known as shingles, to be used in the national immunisation programme. This notice provides an indication to the market of UKHSA’s intention to enter into negotiations with GlaxoSmithKline (UK) Limited, with the objective of awarding a contract for the supply of the herpes zoster, inactivated (shingles) vaccine, in accordance with JCVI advice. ## Contract award Title: Herpes zoster, inactivated vaccine (2027)

Timeline

  1. Completed: Award published13 March 2026
    Current notice
  2. Completed: Award date13 March 2026
  3. Next: Contract expiry date31 March 2029in 3 years

About the buyer

UK Health Security Agency is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 33651600 · Vaccines

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

2 similar open tenders

See more open tenders related to Herpes zoster, inactivated vaccine (2027).

Explore all open tenders

Related topics

Topics related to Herpes zoster, inactivated vaccine (2027), ranked by notice volume.

View all topics
TopicCountValue
  1. 1,745
    £636.1bn

Related buyers

Buyers similar to UK Health Security Agency.

View all buyers

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.